Multiple Assemblies exist for SMTL entry 4uyg
C-Terminal bromodomain of Human BRD2 with I-BET726 (GSK1324726A); X-RAY DIFFRACTION 2.50 Å

	SMTL ID 4uyg.1 Ligands 4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl]benzoic acid; SULFATE ION Polypeptides BROMODOMAIN-CONTAINING PROTEIN 2 Oligo-state monomer
	SMTL ID 4uyg.2 Ligands 4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl]benzoic acid; SULFATE ION Polypeptides BROMODOMAIN-CONTAINING PROTEIN 2 Oligo-state monomer
	SMTL ID 4uyg.3 Ligands 4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl]benzoic acid Polypeptides BROMODOMAIN-CONTAINING PROTEIN 2 Oligo-state monomer
	SMTL ID 4uyg.4 Ligands 4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl]benzoic acid Polypeptides BROMODOMAIN-CONTAINING PROTEIN 2 Oligo-state monomer
	SMTL ID 4uyg.5 Ligands 4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl]benzoic acid Polypeptides BROMODOMAIN-CONTAINING PROTEIN 2 Oligo-state monomer
	SMTL ID 4uyg.6 Ligands 4-[(2S,4R)-1-acetyl-4-[(4-chlorophenyl)amino]-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl]benzoic acid Polypeptides BROMODOMAIN-CONTAINING PROTEIN 2 Oligo-state monomer